secwatch.observer — SEC 8-K summary
======================================

Issuer:     Astrana Health, Inc. (ASTH)
CIK:        0001083446
Form:       8-K
Filed at:   2025-11-06T23:59:59+00:00
Accession:  0001104659-25-107754
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Astrana Health Q3 revenue $956M (+100% YoY); adjusted EBITDA $68.5M; closes Prospect Health
--------------------------------------------------------------------------------

- Total revenue $956.0M, up 100% YoY; Care Partners revenue $897.7M, up 97%.
- Adjusted EBITDA $68.5M, up 52% YoY; net income $0.4M, diluted EPS $0.01.
- Closed Prospect Health acquisition; standalone Q3 performance exceeded expectations.
- Full-year 2025 guidance updated for full-risk contract delays; expects completion in Q1 2026.
- Reiterating full-year medical cost trend expectations; underlying performance strong.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1083446/000110465925107754/0001104659-25-107754-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1083446/000110465925107754/tm2530504d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-107754

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer